Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving hundreds of leading biopharmaceutical companies globally:

Express Scripts
Johnson and Johnson
Farmers Insurance

Generated: August 21, 2019

DrugPatentWatch Database Preview

Patent: 8,440,445

  Try a free trial

See Plans and Pricing

« Back to Dashboard

Summary for Patent: 8,440,445
Title:Neutral protease (NP) and product by using neutral protease for tissue dissociation as well as method for the production thereof
Abstract: The use of a neutral protease (NP) together with a collagenase consists in that a neutral protease which is not contained in a collagenase enzyme preparation and which is not produced by a recombinant production ia mixed before the beginning of a tissue dissociation with a collagenase or a collagenase enzyme preparation with an individual dosage of the quantitative proportions of neutral protease and collagenase for improving the isolation results with respect to yield, viability and integrity of the cells.
Inventor(s): Kurfurst; Manfred (Moorrege, DE), Raemsch; Christian (Uetersen, DE), Raemsch-Guenther; Nicole (Uetersen, DE), Friedrich; Olaf (Tornesch, DE), Huettler; Silke (Uetersen, DE), Brandhorst; Daniel (Linden, DE), Berney; Thierry (Arenthon, FR), Bucher; Pascal (Geneva, CH), Brandhorst; Heide (Linden, DE)
Assignee: Nordmark Arzneimittel GmbH & Co. KG (Uetersen, DE)
Application Number:10/869,313
Patent Claims:see list of patent claims

Details for Patent 8,440,445

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Advance Biofactures SANTYL collagenase VIAL 101995 001 1965-06-04   Try a Free Trial Nordmark Arzneimittel GmbH & Co. KG (Uetersen, DE) 2023-07-09 RX search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Johnson and Johnson
Argus Health
Daiichi Sankyo

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.